Study: Cholesterol was lowered with an oral PCSK9 inhibitor.

Published Date: 08 Mar 2023

A new study conducted by Baylor College of Medicine and presented at the American College of Cardiology Annual Scientific Session as well as the World Congress of Cardiology shows that an oral PCSK9 inhibitor called MK-0616...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Basal stem-like cells identified as origin of small cell lung cancer in lab models

2.

Early Esophageal Cancer pCR Rates Are Raised by Neoadjuvant PD-1 Blockade.

3.

New First-Line Option for Advanced ALK-Positive Lung Cancer

4.

The discovery of drug combinations may increase the life expectancy of children with brain cancer.

5.

Ketamine plus psychotherapy for "excellent" PTSD


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot